DETECT: Development of Technologies for Early HCC Detection.
Jihane N Benhammou, Nicole E Rich, George Cholankeril, Peng Zhang, Weihua Zeng, Shuyun Rao, Nabihah Tayob, National Cancer Institute’s Translational Liver Consortium Early-Career Working Group
Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Jihane N BenhammouVatche and Tamar Manoukian Division of Digestive Diseases at UCLA, Los Angeles, California; Gastroenterology, Hepatology, and Parenteral Nutrition, David Geffen School of Medicine at the VA Greater Los Angeles Healthcare System, Los Angeles, California.
Nicole E RichDivision of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas.
George CholankerilSection of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Peng ZhangDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Weihua ZengDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, California.
Shuyun RaoDepartment of Surgery, George Washington University, Washington, DC; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
Nabihah TayobDana-Farber Cancer Institute, Boston, Massachusetts.
National Cancer Institute’s Translational Liver Consortium Early-Career Working Group
Funding
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
The UCLA Center in Early Detection of Liver CancerU01CA230705 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Vatche Agopian, Samuel Wheeler French · 2018 to 2026
$6.6M
Risk Stratification for and Early Detection of Liver CancerU01CA230997 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Jagpreet Chhatwal, Hashem B El-Serag · 2018 to 2026
$6.4M
Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)U24CA230144 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Ziding Feng · 2018 to 2026
$5.8M
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United StatesU01CA230694 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SINGAL, AMIT · 2018 to 2022
$3.5M
Pathway Specific Functional Biomarkers for the Early Detection of Liver CancerU01CA230690 · NCI · GEORGE WASHINGTON UNIVERSITY · PI MISHRA, LOPA, SHETTY, KIRTI · 2018 to 2022
$3.4M
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTIONU01CA230669 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOK, ANNA S.F., SU, GRACE L. · 2018 to 2022
$3.3M
Novel Computation Methods for the Analysis of Cell-Free DNA Sequence DataR01CA246329 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M., LI, WENYUAN · 2019 to 2022
$2.2M
Biomarker screening algorithms for the improved early detection of hepatocellular carcinomaR01CA230503 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI TAYOB, NABIHAH · 2019 to 2025
$1.6M
Molecular Mechanisms of Stellate Cell Activation in Liver FibrosisI01BX001991 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HIDEKAZU TSUKAMOTO · 2014 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
DETECT: Development of Technologies for Early HCC Detection. · full record | OpenQuestion